COMMUNIQUÉS West-GlobeNewswire

SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
13/01/2026
Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic system FORT LAUDERDALE, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS [...]
Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet
13/01/2026
Company Remains Fully Committed to Advancing Its Core Intranasal Medical Pipeline, alongside examining new opportunities including in fields of aviation, AI and defense Raanana, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE [...]
Propanc Biopharma Provides Shareholder Update
13/01/2026
CEO Highlights Significant Progress Achieved & Outlines Ambitious Plans for 2026 MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a [...]
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
13/01/2026
– Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials – This next-generation anthracycline demonstrates safety and promising early activity in treating multiple oncology [...]
Nu-Tek BioSciences renforce son leadership mondial en matière d’approvisionnement grâce au renouvellement de sa certification Halal
13/01/2026
Ce renouvellement marque plus d’une décennie de conformité Halal, sécurisant les chaînes d’approvisionnement essentielles pour les marchés de croissance biopharmaceutiques jusqu’en 2026 et au-delà. MINNETONKA, Minnesota [...]
Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal
13/01/2026
Renewal marks over a decade of Halal compliance, securing critical supply chains for biopharmaceutical growth markets through 2026 and beyond. MINNETONKA, Minn., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Nu-Tek BioSciences, the [...]
Dror Secures Israeli Regulatory Approval to Market and Sell Its Next Generation Smile Correction Solution
13/01/2026
AMAR regulatory approval will allow the Company to launch ZSmile in Israel in 2026 as a precursor to a larger product launch in the US and Europe JERUSALEM, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. (" [...]
AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39
13/01/2026
KAI 12L, the AI powering Kardia 12L, adds five new detections to further expand diagnostic capabilities for the world's first handheld 12-lead ECG with a unique single-cable design. MOUNTAIN VIEW, Calif., Jan. 13, 2026 [...]
ClinNEXUS Appoints Jovan Hollins to Chief Operating Officer
13/01/2026
- A seasoned healthcare executive with nearly two decades of leadership experience, Mr. Jovan Hollins will lead ClinNEXUS’ operations at a key inflection point in its growth cycle – LOS ANGELES, Jan. 13, 2026 (GLOBE [...]
Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform
13/01/2026
MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced positive results [...]
Picard / SynCardia Featured on the Cruxx of MedTech Podcast
13/01/2026
TUCSON, Ariz., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved [...]
IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring
13/01/2026
American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as a diagnostic marker, a key feature of iMDx’s flagship GraftAssure TM family of assays NASHVILLE, Tenn., [...]
Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care
13/01/2026
Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large, engaged patient population ATLANTA , Jan. 13, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading [...]
Stroke Experts Challenge "90-Day Recovery" Myth: New Research Shows Patients Need Long-Term Care
13/01/2026
Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance policies leave stroke survivors with preventable disabilities and cost society billions BAKERSFIELD, Calif., Jan. [...]
Vericel Announces Preliminary 2025 Financial Results and Business Updates
13/01/2026
Total Revenue Expected to be $276 Million MACI Revenue Expected to be $239.5 Million Fourth Quarter Total Revenue and MACI Revenue Growth of 23% CAMBRIDGE, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation ( [...]
Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging
13/01/2026
Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits, evidence-informed clinical education, and hands-on training for integrative healthcare practitioners PALMYRA, Wis., Jan. 13, 2026 (GLOBE [...]
Conavi Medical Corp. Announces Closing of $12M Public Offering
13/01/2026
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“ Conavi ” or the “ Company ”), a commercial stage [...]
Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
13/01/2026
Data Show Strong Functional and Pain Improvements Supported by Excellent Safety Profile PHOENIX, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “ [...]
Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery
13/01/2026
WEST LAFAYETTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and [...]

Pages